GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised studyFrancesca Bonifazi, Nicolaus Kröger, Carlos Solano et al.|The Lancet Haematology|2019Cited by 58
Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trialWinfried Randerath, Samuel Genzor, J. Bravo Albares et al.|The Lancet|2025Cited by 15